Pati Sunil K, Novak Zdenek, Purser Misty, Arora Nitin, Mach Michael, Britt William J, Boppana Suresh B
Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Clin Vaccine Immunol. 2012 Jun;19(6):909-13. doi: 10.1128/CVI.00092-12. Epub 2012 Apr 4.
The human cytomegalovirus (HCMV) gM-gN complex is a major target of virus-neutralizing activity, and gN subtypes induce strain-specific antibodies. However, the biological significance of HCMV gN polymorphisms is not known. Neutralizing antibody responses against HCMV gN recombinant viruses were investigated at study entry in 80 healthy HCMV-seropositive women who were monitored for the appearance of new antibody specificities against linear strain-specific epitopes on glycoproteins gH and gB as evidence of HCMV reinfection. Neutralizing activity against all four gN recombinant viruses was seen in 74% of subjects, and 61% of subjects had strain-specific responses. Significantly fewer women (9/39 subjects [23%]) with serological evidence of reinfection had strain-specific neutralizing responses than the women without reinfection (21/41 subjects [51%]). Women with antibodies against at least one of the four linear gB and gH antigens at study entry had higher neutralizing titers against gN-1 (P = 0.006) and gN-2 (P = 0.007). Neutralizing titers of ≥400 against gN-3 (P = 0.043) and gN-4 (P = 0.049) at study entry were associated with longer times to serological evidence of reinfection. The findings demonstrate that HCMV gN elicits strain-specific neutralizing antibody responses and that broader anti-gN neutralizing activity may provide some protection from reinfection with a different virus strain.
人类巨细胞病毒(HCMV)gM - gN复合物是病毒中和活性的主要靶点,并且gN亚型可诱导菌株特异性抗体。然而,HCMV gN多态性的生物学意义尚不清楚。在研究开始时,对80名健康的HCMV血清阳性女性进行了针对HCMV gN重组病毒的中和抗体反应研究,这些女性被监测是否出现针对糖蛋白gH和gB上线性菌株特异性表位的新抗体特异性,以此作为HCMV再感染的证据。74%的受试者对所有四种gN重组病毒均有中和活性,61%的受试者有菌株特异性反应。与未再感染的女性(21/41名受试者[51%])相比,有再感染血清学证据的女性(9/39名受试者[23%])出现菌株特异性中和反应的人数明显更少。在研究开始时,针对四种线性gB和gH抗原中至少一种有抗体的女性对gN - 1(P = 0.006)和gN - 2(P = 0.007)的中和滴度更高。在研究开始时,针对gN - 3(P = 0.043)和gN - 4(P = 0.049)的中和滴度≥400与出现再感染血清学证据的时间更长相关。这些发现表明,HCMV gN可引发菌株特异性中和抗体反应,更广泛的抗gN中和活性可能为预防不同病毒菌株的再感染提供一定保护。